 |
|
Global incidence and prevalence of nonalcoholic fatty liver disease
Margaret LP Teng, Cheng Han Ng, Daniel Q. Huang, Kai En Chan, Darren JH Tan, Wen Hui Lim, Ju Dong Yang, Eunice Tan, Mark D. Muthiah
Clin Mol Hepatol. 2023;29(Suppl):S32-S42. Published online 2022 Dec 14 DOI: https://doi.org/10.3350/cmh.2022.0365
|
|
Citations to this article as recorded by
 Development of non-alcoholic steatohepatitis is associated with gut microbiota but not with oxysterol enzymes CH25H, EBI2, or CYP7B1 in mice
Jacqueline Wyss, Tina Raselli, Annika Wyss, Anja Telzerow, Gerhard Rogler, Niklas Krupka, Bahtiyar Yilmaz, Thomas S. B. Schmidt, Benjamin Misselwitz
BMC Microbiology.2024;[Epub] CrossRef Dose finding for ZSP1601 in patients with nonalcoholic steatohepatitis using population pharmacokinetics and exposure–response approach
Haijun Li, Yue Hu, Yuting Yang, Fengyan Xu, Zhongyi Sun, Jufang Huang, Kun Wang, Xiaoxin Chen
European Journal of Pharmaceutical Sciences.2024; 199: 106808. CrossRef Assessment of melatonin’s therapeutic effectiveness against hepatic steatosis induced by a high-carbohydrate high-fat diet in rats
Davood Dorranipour, Fahimeh Pourjafari, Reza Malekpour-Afshar, Mohsen Basiri, Mehran Hosseini
Naunyn-Schmiedeberg's Archives of Pharmacology.2024; 397(5): 2971. CrossRef Association of five diet scores with severe NAFLD incidence: A prospective study from UK Biobank
Fanny Petermann‐Rocha, Fernanda Carrasco‐Marin, Jirapitcha Boonpor, Solange Parra‐Soto, Oliver Shannon, Fiona Malcomson, Nathan Phillips, Mahek Jain, Salil Deo, Katherine M. Livingstone, Sara E. Dingle, John C. Mathers, Ewan Forrest, Frederick K. Ho, Jill
Diabetes, Obesity and Metabolism.2024; 26(3): 860. CrossRef The effects of pomegranate consumption on liver function enzymes in adults: A systematic review and meta-analysis
Hossein Bahari, Hossein Rafiei, Kian Goudarzi, Kosar Omidian, Omid Asbaghi, Kosar Sadat Hosseini Kolbadi, Moslem Naderian, Ali Hosseini
Complementary Therapies in Medicine.2024; 80: 103008. CrossRef BDE-47 induces metabolic dysfunction-associated steatotic liver disease (MASLD) through CD36-mediated increased fatty acid uptake and PPARα-induced abnormal fatty acid oxidation in BALB/c mice
Beibei Xia, Rongfei Yu, Junxiong Liu, Dongmeng Liu, Shasha Li, Liu Yang, Nan Liu, Bosen Liang, Jiajing Zeng, Jinhua Wei, Guimiao Lin
Toxicology Letters.2024; 391: 100. CrossRef Multifocal fatty liver nodules mimicking a metastatic disease: A case report
Huy Quang Duong, Shinya Kajiura, Tien Dinh Truong, Minh Tuan Ngo, Khai Xuan Nguyen, Hung Khanh Pham, Thang Ba Ta, Dung Tien Nguyen, Ryuji Hayashi
Radiology Case Reports.2024; 19(3): 850. CrossRef Role of Perturbated Hemostasis in MASLD and Its Correlation with Adipokines
Salvatore Pezzino, Tonia Luca, Mariacarla Castorina, Stefano Puleo, Saverio Latteri, Sergio Castorina
Life.2024; 14(1): 93. CrossRef The Intersection of Genetic Factors, Aberrant Nutrient Metabolism and Oxidative Stress in the Progression of Cardiometabolic Disease
Andrew J. Butcko, Ashley K. Putman, Emilio P. Mottillo
Antioxidants.2024; 13(1): 87. CrossRef Bacillus coagulans TCI711 Supplementation Improved Nonalcoholic Fatty Liver by Modulating Gut Microbiota: A Randomized, Placebo-Controlled, Clinical Trial
Rong-Hong Hsieh, Yu-Ju Chien, Wen-Yi Lan, Yung-Kai Lin, Yung-Hsiang Lin, Chi-Fu Chiang, Ming-Ta Yang
Current Developments in Nutrition.2024; 8(3): 102083. CrossRef Altered lipid metabolism as a predisposing factor for liver metastasis in MASLD
So Jung Kim, Jeongeun Hyun
Molecules and Cells.2024; 47(2): 100010. CrossRef Steatotic liver disease predicts cardiovascular disease and advanced liver fibrosis: A community-dwelling cohort study with 20-year follow-up
Hun Jee Choe, Joon Ho Moon, Won Kim, Bo Kyung Koo, Nam H. Cho
Metabolism.2024; 153: 155800. CrossRef Association between dairy-rich dietary pattern and metabolic dysfunction-associated steatotic liver disease: Findings from the Korean Genome and Epidemiology Study
Jong Hee Lee, Hye Sun Lee, Soyoung Jeon, Jun-Hyuk Lee, Yu-Jin Kwon
Digestive and Liver Disease.2024;[Epub] CrossRef Beneficial Effects of Dietary Flaxseed on Non-Alcoholic Fatty Liver Disease
Mihir Parikh, Broderick C. Hirst, Kimberley A. O’Hara, Thane G. Maddaford, J. Alejandro Austria, Aleksandra Stamenkovic, Liping Yu, Branislav Kura, Bhavana Garg, Thomas Netticadan, Spencer D. Proctor, Grant N. Pierce
Nutrients.2024; 16(4): 466. CrossRef The Portal Venous Pulsatility Index and Main Portal Vein Diameter as Surrogate Markers for Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Metabolic-Dysfunction-Associated Steatotic Liver Disease
Jaejun Lee, Seungmyeon Choi, Seong-Hyun Cho, Hyun Yang, Pil-Soo Sung, Si-Hyun Bae
Diagnostics.2024; 14(4): 393. CrossRef Association between healthy beverage index and nonalcoholic fatty liver disease in the Ravansar noncommunicable disease cohort study
Sepehr Sadafi, Ali Azizi, Shahab Rezaeian, Yahya Pasdar
Scientific Reports.2024;[Epub] CrossRef Upper limit of normal ALT levels in health and metabolic diseases: Pooled analysis of 423,355 individuals with bootstrap modelling
Eunice X. Tan, Daniel Q. Huang, Natasha Tang Sook Yee, Zi Hui Wan, Sanjna N. Nerurkar, Justin Chua Ying Kai, Kang Shiong Goh, Cheng Han Ng, Mark Muthiah, Yu Zhou, Amanda Woodward, Michael H. Le, Yee Hui Yeo, Scott Barnett, Ramsey Cheung, Mindie H. Nguyen
Alimentary Pharmacology & Therapeutics.2024; 59(8): 984. CrossRef Assessing the clinical and biochemical efficacy of alpha-lipoic acid in patients with non-alcoholic fatty liver disease: A randomized placebo-controlled clinical trial
Mehrangiz Ebrahimi-Mameghani, Somayyeh Asghari, Fatemeh Naeini, Mahdiyeh Taghizadeh, Soudabeh Hamedi-Shahraki, Farshad Amirkhizi
Journal of Functional Foods.2024; 114: 106050. CrossRef Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
Mohamed El-Kassas, Abeer Awad, Mohamed Elbadry, Juan Pablo Arab
Seminars in Liver Disease.2024; 44(01): 054. CrossRef Perilipin 5 deletion protects against nonalcoholic fatty liver disease and hepatocellular carcinoma by modulating lipid metabolism and inflammatory responses
Paola Berenice Mass-Sanchez, Marinela Krizanac, Paula Štancl, Marvin Leopold, Kathrin M. Engel, Eva Miriam Buhl, Josef van Helden, Nikolaus Gassler, Jürgen Schiller, Rosa Karlić, Diana Möckel, Twan Lammers, Steffen K. Meurer, Ralf Weiskirchen, Anastasia A
Cell Death Discovery.2024;[Epub] CrossRef The Interplay Between Dietary Choline and Cardiometabolic Disorders: A Review of Current Evidence
Natalia G. Vallianou, Dimitris Kounatidis, Sotiria Psallida, Fotis Panagopoulos, Theodora Stratigou, Eleni Geladari, Irene Karampela, Dimitrios Tsilingiris, Maria Dalamaga
Current Nutrition Reports.2024; 13(2): 152. CrossRef Metabolic Dysfunction-Associated Steatotic Liver Disease in a Dish: Human Precision-Cut Liver Slices as a Platform for Drug Screening and Interventions
Mei Li, Frederik T. Larsen, Marius C. van den Heuvel, Konstanze Gier, Alan R. Gorter, Dorenda Oosterhuis, Johan Bijzet, Vincent E. de Meijer, Kim Ravnskjaer, Anika Nagelkerke, Peter Olinga
Nutrients.2024; 16(5): 626. CrossRef Advancing Endocrine Disruptors via In Vitro Evaluation: Recognizing the Significance of the Organization for Economic Co-Operation and Development and United States Environmental Protection Agency Guidelines, Embracing New Assessment Methods, and the Urge
Sophie Fouyet, Marie-Caroline Ferger, Pascale Leproux, Patrice Rat, Mélody Dutot
Toxics.2024; 12(3): 183. CrossRef Therapeutic potential of Triphala and Gomutra in the management of non-alcoholic fatty liver disease: A review
M S Deepa, V C Indulekha, Indu M Menon
Journal of Drug Research in Ayurvedic Sciences.2024; 9(1): 8. CrossRef Role of Vibration-Controlled Transient Elastography in the Evaluation and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease
Elizabeth E. Williams, Raj Vuppalanchi
Current Hepatology Reports.2024;[Epub] CrossRef 4,4‐Diallyl curcumin bis(2,2‐hydroxymethyl)propanoate ameliorates nonalcoholic steatohepatitis in methionine‐choline‐deficient diet and Western diet mouse models
Li‐Chan Yang, Chih‐Chiang Wang, Der‐Yen Lee, Wen‐Chuan Lin, Sheng‐Chu Kuo, Shin‐Hun Juang, Min‐Tsang Hsieh
Chemical Biology & Drug Design.2024;[Epub] CrossRef Adipocytokines as Predictors of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Development in Type 2 Diabetes Mellitus Patients
Almir Fajkić, Rijad Jahić, Almira Hadžović-Džuvo, Orhan Lepara
Cureus.2024;[Epub] CrossRef Beyond the hype and toward application: liver complex in vitro models in preclinical drug safety
Sushma Jadalannagari, Lorna Ewart
Expert Opinion on Drug Metabolism & Toxicology.2024; : 1. CrossRef Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe
Maria Eleni Chondrogianni, Ioannis Kyrou, Theodoros Androutsakos, Christina-Maria Flessa, Evangelos Menenakos, Kamaljit Kaur Chatha, Yekaterina Aranan, Athanasios G. Papavassiliou, Eva Kassi, Harpal S. Randeva
Frontiers in Endocrinology.2024;[Epub] CrossRef Interleukins: Pathogenesis in Non-Alcoholic Fatty Liver Disease
Saira Rafaqat, Sanja Gluscevic, Filiz Mercantepe, Sana Rafaqat, Aleksandra Klisic
Metabolites.2024; 14(3): 153. CrossRef Glucocorticoid resistance remodels liver lipids and prompts lipogenesis, eicosanoid, and inflammatory pathways
Genesee J. Martinez, Zachary A. Kipp, Wang-Hsin Lee, Evelyn A. Bates, Andrew J. Morris, Joseph S. Marino, Terry D. Hinds
Prostaglandins & Other Lipid Mediators.2024; 173: 106840. CrossRef Depalmitoylation and cell physiology: APT1 as a mediator of metabolic signals
Sarah L. Speck, Xiaochao Wei, Clay F. Semenkovich
American Journal of Physiology-Cell Physiology.2024; 326(4): C1034. CrossRef Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review
Haider Ghazanfar, Nismat Javed, Abeer Qasim, George Sarin Zacharia, Ali Ghazanfar, Abhilasha Jyala, Elona Shehi, Harish Patel
Cancers.2024; 16(6): 1214. CrossRef Effects of Resveratrol on Liver Function Tests in Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis of Randomized Controlled Trials
P. Ebrahimpour, M. Karamian, A. Sharifi
Russian Journal of Gastroenterology, Hepatology, Coloproctology.2024; 34(1): 37. CrossRef Effect of Gracilaria vermiculophylla Macroalga on Non-Alcoholic Fatty Liver Disease in Obese Rats
Maitane González-Arceo, Leixuri Aguirre, María Teresa Macarulla, Clàudia Gil-Pitarch, María Luz Martínez-Chantar, María P. Portillo, Saioa Gómez-Zorita
Antioxidants.2024; 13(3): 369. CrossRef Response to Article “Effect of Helicobacter Pylori Infection on Glucose Metabolism, Lipid Metabolism and Inflammatory Cytokines in Nonalcoholic Fatty Liver Disease Patients” [Letter]
Putu Yuliandari, I Putu Bayu Mayura
Journal of Multidisciplinary Healthcare.2024; Volume 17: 1413. CrossRef Possibilities of a new assessment scale for prediction of chronic liver disease “CLivD”
L. B. Lazebnik, S. V. Turkina
Experimental and Clinical Gastroenterology.2024; (11): 62. CrossRef Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?
Kamila Kasprzak-Drozd, Przemysław Niziński, Paulina Kasprzak, Adrianna Kondracka, Tomasz Oniszczuk, Agata Rusinek, Anna Oniszczuk
International Journal of Molecular Sciences.2024; 25(7): 3746. CrossRef Bariatrics and endoscopic therapies for the treatment of metabolic disease: Past, present, and future
Geltrude Mingrone, Harith Rajagopalan
Diabetes Research and Clinical Practice.2024; 211: 111651. CrossRef NAFLD in the 21st Century: Current Knowledge Regarding Its Pathogenesis, Diagnosis and Therapeutics
Dimitris Kounatidis, Natalia G. Vallianou, Eleni Geladari, Maria Paraskevi Panoilia, Anna Daskou, Theodora Stratigou, Irene Karampela, Dimitrios Tsilingiris, Maria Dalamaga
Biomedicines.2024; 12(4): 826. CrossRef Namodenoson at the Crossroad of Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma
Ohad Etzion, Avital Bareket-Samish, David Yardeni, Pnina Fishman
Biomedicines.2024; 12(4): 848. CrossRef Association between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction: A 7-year retrospective cohort study of 3,380 adults using serial echocardiography
Gyuri Kim, Tae Yang Yu, Jae Hwan Jee, Ji Cheol Bae, Mira Kang, Jae Hyeon Kim
Diabetes & Metabolism.2024; 50(3): 101534. CrossRef The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation
Ludovico Abenavoli, Maria Luisa Gambardella, Giuseppe Guido Maria Scarlata, Ilaria Lenci, Leonardo Baiocchi, Francesco Luzza
Medicina.2024; 60(4): 563. CrossRef Gestational supplementation of Bifidobacterium, Lactobacillus, and Streptococcus thermophilus attenuates hepatic steatosis in offspring mice through promoting fatty acid β‐oxidation
Hangjun Chen, Qiongmei Wu, Xingyi Chen, Xinxue Yu, Hanqing Zhao, Qiaoli Huang, Yurong Huang, Jinting Wang, Xueyi Huang, Jun Wei, Feng Wu, Xiaomin Xiao, Lijun Wang
Journal of Food Science.2024; 89(5): 3064. CrossRef Changes in the terminology and diagnostic criteria of non-alcoholic fatty liver disease: Implications and opportunities
Muhammed Mubarak
World Journal of Gastrointestinal Pathophysiology.2024;[Epub] CrossRef Non-alcoholic fatty liver disease: a current challenge of interdisciplinary research
E. V. Biryukova
Meditsinskiy sovet = Medical Council.2024; (6): 72. CrossRef Can Plasma Volume Determination in Cirrhosis Be Replaced by an Algorithm Using Body Weight and Hematocrit?
Martine Prütz Nørskov, Thormod Mønsted, Nina Kimer, Morten Damgaard, Søren Møller
Diagnostics.2024; 14(8): 835. CrossRef From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences
Ahmed M. Samy, Mohamed A. Kandeil, Dina Sabry, A.A. Abdel-Ghany, Mohamed O. Mahmoud
Heliyon.2024; 10(9): e30387. CrossRef Efficacy and safety of aldafermin in non-alcoholic steatohepatitis: A systematic review and meta-analysis of randomized controlled trials
Mohamed Mahmoud Marey, Mohamed Belal, Abdelaziz A. Awad, Eslam Mohammed Rabea, Malak A. Hassan, Ahmed W. Abbas, Abdulqadir J. Nashwan
Clinics and Research in Hepatology and Gastroenterology.2024; 48(6): 102357. CrossRef A prospective observational cross-sectional study on the association of non-alcoholic fatty liver disease and insulin resistance in acute ischemic stroke in tertiary care hospital in Central India
Dr. Jayanth Kumar, Dr Anuj Varma, Dr Sourya Acharya, Dr Sunil Kumar
F1000Research.2024; 13: 434. CrossRef Liver steatosis in patients with transfusion‐dependent thalassaemia
Paolo Ricchi, Laura Pistoia, Vincenzo Positano, Anna Spasiano, Tommaso Casini, Maria Caterina Putti, Zelia Borsellino, Antonella Cossu, Giuseppe Messina, Petra Keilberg, Carmina Fatigati, Silvia Costantini, Stefania Renne, Giuseppe Peritore, Filippo Cadem
British Journal of Haematology.2024; 204(6): 2458. CrossRef Diagnostic performances of Fibrosis‐4 index and nonalcoholic fatty liver disease fibrosis score in metabolic dysfunction‐associated steatotic liver disease in Asian primary care clinics
Huiyul Park, Mimi Kim, Hye‐Lin Kim, Seon Cho, Eileen L. Yoon, Dae Won Jun
Hepatology Research.2024;[Epub] CrossRef LDL-C and TC Mediate the Risk of PNPLA3 Inhibition in Cardiovascular Diseases
Genshan Zhang, Wei Jiang, Fangxun He, Jie Fu, Xiangshang Xu, Xuelai Luo, Zhixin Cao
The Journal of Clinical Endocrinology & Metabolism.2024;[Epub] CrossRef Obesity, liver steatosis and metabolic syndrome: The hidden enemies in transfusion‐dependent thalassaemia
Padmapani Padeniya, Anuja Premawardhena
British Journal of Haematology.2024;[Epub] CrossRef Personalized medicine and nutrition in hepatology for preventing chronic liver disease in Mexico
Arturo Panduro, Sonia Roman, Irene M. Mariscal-Martinez, Alexis Jose-Abrego, Karina Gonzalez-Aldaco, Claudia Ojeda-Granados, Omar Ramos-Lopez, Luis A. Torres-Reyes
Frontiers in Nutrition.2024;[Epub] CrossRef Management of Cardiovascular Risk in the Non‑alcoholic Fatty Liver Disease Setting
Paula Luque-Linero, Luis Castilla-Guerra
European Cardiology Review.2024;[Epub] CrossRef WFUMB Guideline/Guidance on Liver Multiparametric Ultrasound: Part 1. Update to 2018 Guidelines on Liver Ultrasound Elastography
Giovanna Ferraioli, Richard Gary Barr, Annalisa Berzigotti, Ioan Sporea, Vincent Wai‐Sun Wong, Thomas Reiberger, Thomas Karlas, Maja Thiele, Ana Carolina Cardoso, Oyekoya Taiwo Ayonrinde, Laurent Castera, Christoph Frank Dietrich, Hiroko Iijima, Dong Ho L
Ultrasound in Medicine & Biology.2024; 50(8): 1071. CrossRef Metabolic dysfunction associated steatotic liver disease in patients with plaque psoriasis: a case–control study and serological comparison
Zheng Lin, Yue-yi Shi, Lu-yan Yu, Chen-xi Ma, Si-yi Pan, Yuan Dou, Qiu-jun Zhou, Yi Cao
Frontiers in Medicine.2024;[Epub] CrossRef MASLD-mimicking microenvironment drives an aggressive phenotype and represses IDH2 expression in hepatocellular carcinoma
Peyda Korhan, Ezgi Bağırsakçı, Yasemin Öztemur Islakoğlu, Gülhas Solmaz, Burcu Sarıkaya, Deniz Nart, Funda Yılmaz, Neşe Atabey
Hepatoma Research.2024;[Epub] CrossRef Combined Insults of a MASH Diet and Alcohol Binges Activate Intercellular Communication and Neutrophil Recruitment via the NLRP3-IL-1β Axis in the Liver
Mrigya Babuta, Prashanth Thevkar Nagesh, Aditi Ashish Datta, Victoria Remotti, Yuan Zhuang, Jeeval Mehta, Francesca Lami, Yanbo Wang, Gyongyi Szabo
Cells.2024; 13(11): 960. CrossRef Prebiotic Treatment in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)—A Randomized Pilot Trial
Naama Reshef, Uri Gophna, Leah Reshef, Fred Konikoff, Gila Gabay, Taiba Zornitzki, Hilla Knobler, Yaakov Maor
Nutrients.2024; 16(11): 1571. CrossRef Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD
Farah Abdelhameed, Chris Kite, Lukasz Lagojda, Alexander Dallaway, Kamaljit Kaur Chatha, Surinderjeet S. Chaggar, Maria Dalamaga, Eva Kassi, Ioannis Kyrou, Harpal S. Randeva
Current Obesity Reports.2024;[Epub] CrossRef Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy
Bhagyalakshmi Nair, Adithya Jayaprakash Kamath, Vinay Tergaonkar, Gautam Sethi, Lekshmi R. Nath
Life Sciences.2024; 351: 122818. CrossRef Emerging Role of Natural Lipophagy Modulators in MASLD
Nahla E. El-Ashmawy, Eman G. Khedr, Ghada M. Al-Ashmawy, Asmaa A. Kamel
Nutrition.2024; : 112517. CrossRef Unravelling the complexities of non-alcoholic steatohepatitis: The role of metabolism, transporters, and herb-drug interactions
Ravi Adinarayan Somabattini, Sahla Sherin, Bhukya Siva, Neelanjan Chowdhury, Satheesh Kumar Nanjappan
Life Sciences.2024; 351: 122806. CrossRef Clinical improvement effect of regulating gut microbiota on metabolic dysfunction-associated steatotic liver disease: systematic review and meta-analysis of randomized controlled trials
Juan Wu, Xiaoyang Chen, Jun Qian, Guochun Li
Clinics and Research in Hepatology and Gastroenterology.2024; : 102397. CrossRef Interplay of Mediterranean-diet adherence, genetic factors, and metabolic dysfunction-associated steatotic liver disease risk in Korea
Yu-Jin Kwon, Ja-Eun Choi, Kyung-Won Hong, Ji-Won Lee
Journal of Translational Medicine.2024;[Epub] CrossRef Diagnostic performance of sixteen biomarkers for MASLD: A study in a Mexican cohort
Bryan Adrian Priego-Parra, Sara Alejandra Reyes-Diaz, Héctor Ricardo Ordaz-Alvarez, Raúl Bernal-Reyes, Maria Eugenia Icaza-Chávez, Sophia Eugenia Martínez-Vázquez, Mercedes Amieva-Balmori, Héctor Vivanco-Cid, José Antonio Velarde-Ruiz Velasco, Jordi Graci
Clinics and Research in Hepatology and Gastroenterology.2024; 48(7): 102400. CrossRef Evaluation of the diagnostic role of circulating miR-16, miR-10b, and miR-21 expression in patients with nonalcoholic fatty liver disease
Fatemeh Amani, Amirhossein Sahebkar, Seyed Hamid Aghaee-Bakhtiari, Mohammadreza Farzanehfar, Saeedeh Askarian, Reza Kazemi Oskuee
Gene Reports.2024; : 101964. CrossRef Bifidobacterium longumBL‐19 inhibits oxidative stress and inflammatory damage in the liver of mice with NAFLD by regulating the production of butyrate in the intestine
Xiajun Zhang, Jingwen Xu, Xueyun Dong, Jiajun Tang, Yan Xie, Jie Yang, Limin Zou, Liang Wu, Jilong Fan
Food Science & Nutrition.2024;[Epub] CrossRef Targeting cAMP signaling and phosphodiesterase 4 for liver disease treatment
Jingyi Ma, Dalton W. Staler, Ram I. Mahato
Medicinal Chemistry Research.2024;[Epub] CrossRef Mapping global research trends: Nutrition associations with nonalcoholic fatty liver disease - a Scopus bibliometric analysis
Muna Shakhshir, Sa'ed H Zyoud
World Journal of Gastroenterology.2024; 30(24): 3106. CrossRef The systemic inflammation response index as a risk factor for hepatic fibrosis and long-term mortality among individuals with metabolic dysfunction-associated steatotic liver disease
Yufeng Yin, Weijia Zhu, Qingling Xu
Nutrition, Metabolism and Cardiovascular Diseases.2024;[Epub] CrossRef Mapping the global research landscape on nonalcoholic fatty liver disease and insulin resistance: A visualization and bibliometric study
Sa'ed H Zyoud, Omar E Hegazi, Samer O Alalalmeh, Muna Shakhshir, Faris Abushamma, Shadi Khilfeh, Samah W Al-Jabi
World Journal of Hepatology.2024; 16(6): 951. CrossRef Evaluation of the role of some non-enzymatic antioxidants among Iraqi patients with non-alcoholic fatty liver disease
Ammar L. Hussein, Dunia T. Nema, Gulboy A. Nasir
Open Life Sciences.2024;[Epub] CrossRef Effect of synbiotic supplementation on liver function, metabolic profile and gut microbiota in non-alcoholic fatty liver disease (NAFLD): A meta-analysis of randomized controlled trials
Jihan Fadhilah, Hainun Zariyah, Adriyan Pramono, Hery Djagat Purnomo, Ahmad Syauqy, Diana Nur Afifah, Farhan Syafiq Fadhillah, Rachmania Anggita Purwanti
Clinical Nutrition Open Science.2024; 56: 128. CrossRef Endogenous n-3 PUFAs Improve Non-Alcoholic Fatty Liver Disease through FFAR4-Mediated Gut–Liver Crosstalk
Xuan Jiang, Qin Yang, Hongyan Qu, Yongquan Chen, Shenglong Zhu
Nutrients.2023; 15(3): 586. CrossRef Editorial: clinical outcomes in lean NAFLD—the devil is in the details
Eunice X. X. Tan, Mark Dhinesh Muthiah, Cheng Han Ng, Daniel Q. Huang
Alimentary Pharmacology & Therapeutics.2023; 57(9): 1040. CrossRef Noninvasive Assessment of Liver Fibrosis in NAFLD
Arun J. Sanyal, Laurent Castera, Vincent Wai-Sun Wong
Clinical Gastroenterology and Hepatology.2023; 21(8): 2026. CrossRef Nonalcoholic fatty liver disease in polycystic ovary syndrome: Result of a single-center cross-sectional study in Bangladesh
HafejaAkhter Hima, MdAbdul Hannan Miah, NipaRani Ghosh, Sazia Sultana, Tanjina Akter, FatemaTuz Zahura Aalpona, AB. M. Kamrul-Hasan
Bangladesh Journal of Endocrinology and Metabolism.2023; 2(2): 80. CrossRef The Role of GLP1-RAs in Direct Modulation of Lipid Metabolism in Hepatic Tissue as Determined Using In Vitro Models of NAFLD
Ana Petrovic, Dunja Igrec, Karla Rozac, Kristina Bojanic, Lucija Kuna, Tea Omanovic Kolaric, Vjera Mihaljevic, Renata Sikora, Robert Smolic, Marija Glasnovic, George Y. Wu, Martina Smolic
Current Issues in Molecular Biology.2023; 45(6): 4544. CrossRef Close association of PFASs exposure with hepatic fibrosis than steatosis: evidences from NHANES 2017–2018
Wenli Cheng, Min Li, Luyun Zhang, Cheng Zhou, Xinyu Zhang, Chenyu Zhu, Luyi Tan, Hui Lin, Wenjuan Zhang, Wenji Zhang
Annals of Medicine.2023;[Epub] CrossRef Heterozygous midnolin knockout attenuates severity of nonalcoholic fatty liver disease in mice fed a Western-style diet high in fat, cholesterol, and fructose
Soo-Mi Kweon, Jose Irimia-Dominguez, Gayeoun Kim, Patrick T. Fueger, Kinji Asahina, Keith K. Lai, Daniela S. Allende, Quincy R. Lai, Chih-Hong Lou, Walter M. Tsark, Ju Dong Yang, Dominic S. Ng, Ju-Seog Lee, Patrick Tso, Wendong Huang, Keane K. Y. Lai
American Journal of Physiology-Gastrointestinal and Liver Physiology.2023; 325(2): G147. CrossRef Synergistic Preventive Effect of Aerobic and Resistance Exercises on Nonalcoholic Fatty Liver Disease
Ju-Yeon Cho, Won Sohn
Gut and Liver.2023; 17(4): 487. CrossRef Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments
Lucy Petagine, Mohammed Gulrez Zariwala, Vinood B Patel
World Journal of Gastroenterology.2023; 29(32): 4831. CrossRef Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target
Yuan Yao, Yunfeng Shen
Open Life Sciences.2023;[Epub] CrossRef The silent burden of non‐alcoholic fatty liver disease in the elderly: A global burden of disease analysis
Pojsakorn Danpanichkul, Cheng Han Ng, Mark D. Muthiah, Kwanjit Duangsonk, Jie Ning Yong, Darren Jun Hao Tan, Wen Hui Lim, Zhen Yu Wong, Nicholas Syn, Tsubasa Tsusumi, Hirokazu Takahashi, Mohammad Shadab Siddiqui, Vincent Wai‐Sun Wong, Christos S. Mantzoro
Alimentary Pharmacology & Therapeutics.2023; 58(10): 1062. CrossRef Ameliorative Effects of Anthocyanin Metabolites on Western Diet-Induced NAFLD by Modulating Co-Occurrence Networks of Gut Microbiome
Hironobu Nakano, Kozue Sakao, Koji Wada, De-Xing Hou
Microorganisms.2023; 11(10): 2408. CrossRef Challenges and Solutions in the Management of Hepatocellular Carcinoma Associated with Non-Alcoholic Fatty Liver Disease
Ramona Cadar, Corina Lupascu Ursulescu, Alin Mihai Vasilescu, Ana Maria Trofin, Mihai Zabara, Delia Rusu-Andriesi, Bogdan Ciuntu, Cristina Muzica, Cristian Dumitru Lupascu
Life.2023; 13(10): 1987. CrossRef Uncovering the Cardiovascular Threat: A Comprehensive Examination of Liver Fibrosis and Subclinical Atherosclerosis in Non-alcoholic Fatty Liver Disease
Niketa Sharma, Swarupa Chakole, Bhushan Wandile
Cureus.2023;[Epub] CrossRef Unveiling the role of gut dysbiosis in non-alcoholic fatty liver disease
Pranali A. Jadhav, Asha B. Thomas, Rabindra K. Nanda, Sohan S. Chitlange
European Journal of Gastroenterology & Hepatology.2023; 35(12): 1324. CrossRef Decellularization Techniques for Tissue Engineering: Towards Replicating Native Extracellular Matrix Architecture in Liver Regeneration
Ishita Allu, Ajay Kumar Sahi, Meghana Koppadi, Shravanya Gundu, Alina Sionkowska
Journal of Functional Biomaterials.2023; 14(10): 518. CrossRef Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases
Yankai Wen, Lichun Ma, Cynthia Ju
eGastroenterology.2023; 1(2): e100020. CrossRef Exploring the underlying mechanisms of Ashitaba in the management of non-alcoholic fatty liver disease by integrating the analysis of transcriptomics and metabolomics
Huan Yang, Yunshan Li, Weihong Xu, Wenjuan Liu, Ying Xie
Frontiers in Medicine.2023;[Epub] CrossRef The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
Teodora Biciusca, Sorina Ionelia Stan, Mara Amalia Balteanu, Ramona Cioboata, Alice Elena Ghenea, Suzana Danoiu, Ana-Maria Bumbea, Viorel Biciusca
Diagnostics.2023; 13(21): 3316. CrossRef Pegozafermin Is a Potential Master Therapeutic Regulator in Metabolic Disorders: A Review
Nadian N. Bailey, Stephen J. Peterson, Manish A. Parikh, Kaedrea A. Jackson, William H. Frishman
Cardiology in Review.2023;[Epub] CrossRef Pentadecanoic Acid (C15:0), an Essential Fatty Acid, Shares Clinically Relevant Cell-Based Activities with Leading Longevity-Enhancing Compounds
Stephanie Venn-Watson, Nicholas J. Schork
Nutrients.2023; 15(21): 4607. CrossRef Association or causation: still more questions than answers in early-onset gastrointestinal cancers
E. Fontana, I. Ben-Aharon
ESMO Gastrointestinal Oncology.2023; 1: 40. CrossRef The Role of Epigenetic Control of Mitochondrial (Dys)Function in MASLD Onset and Progression
Valerio Caputo, Giovanni Tarantino, Silvano Junior Santini, Giovanna Fracassi, Clara Balsano
Nutrients.2023; 15(22): 4757. CrossRef Unraveling the Connection between Fatty Liver Severity with Gender, Lifestyle, and Health Risks among Workers
Feng-Cheng Tang, Ren-Hau Li, Jui-Hua Huang
Nutrients.2023; 15(22): 4765. CrossRef Nonalcoholic Fatty Liver Disease as a Systemic Disease and the Need for Multidisciplinary Care
Masato Yoneda, Takashi Kobayashi, Michihiro Iwaki, Asako Nogami, Satoru Saito, Atsushi Nakajima
Gut and Liver.2023; 17(6): 843. CrossRef Editorial: Interactions between NAFLD and cardiac conduction, structure and function: recent advances and treatments
Christiano Argano
Frontiers in Endocrinology.2023;[Epub] CrossRef Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
Cheng-Wei Yu, Chia-Hung Chen, Yung-Chi Cheng, Wen-Che Hsieh, Tzu-Ju Hsu, Fuu-Jen Tsai, Chao-Yu Hsu
European Journal of Medical Research.2023;[Epub] CrossRef Trends of nonalcoholic fatty liver research in Southeast Asia from 2004 to 2022: A bibliometric analysis
Vivien Joyce D. Josol, Paul Benedic U. Salvador, Linnaeus Louisse A. Cruz, Eric David B. Ornos, Ourlad Alzeus G. Tantengco
Obesity Medicine.2023; : 100527. CrossRef Reduced Lipopolysaccharide-Binding Protein (LBP) Levels Are Associated with Non-Alcoholic Fatty Liver Disease (NAFLD) and Adipose Inflammation in Human Obesity
Ilaria Barchetta, Flavia Agata Cimini, Federica Sentinelli, Caterina Chiappetta, Claudio Di Cristofano, Gianfranco Silecchia, Frida Leonetti, Marco Giorgio Baroni, Maria Gisella Cavallo
International Journal of Molecular Sciences.2023; 24(24): 17174. CrossRef A Comprehensive Review on Non-Alcoholic Fatty Liver Disease
Prerna Sahu, Pratyaksh Chhabra, Ashok M Mehendale
Cureus.2023;[Epub] CrossRef Developmental Programming: Impact of Prenatal Exposure to Bisphenol A on Senescence and Circadian Mediators in the Liver of Sheep
Giuliana Motta, Soundara Viveka Thangaraj, Vasantha Padmanabhan
Toxics.2023; 12(1): 15. CrossRef Ameliorative role of bioactive phytoconstituents targeting obesity associated NAFLD by modulation of inflammation and lipogenesis pathways: a comprehensive review
Pervej Alom Barbhuiya, Saikat Sen, Manash Pratim Pathak
Phytochemistry Reviews.2023;[Epub] CrossRef
|